Mutation Information
Mutation Site
|
L90M |
Mutation Type
|
Amino acid level |
Gene/Protein/Region Type
|
PR |
Relevant Drug
|
PIs |
Country
|
Namibia |
Literature Information
PubMed PMID
|
30568984
|
Disease
|
HIV infection/AIDS
|
Published Year
|
2018 |
Journal
|
Open forum infectious diseases |
Title
|
Human Immunodeficiency Virus-1 Drug Resistance Patterns Among Adult Patients Failing Second-Line Protease Inhibitor-Containing Regimens in Namibia, 2010-2015. |
Author
|
Sawadogo S,Shiningavamwe A,Roscoe C,Baughman AL,Negussie T,Mutandi G,Yang C,Hamunime N,Agolory S |
Evidence
|
The prevalence of the most common mutations observed for NRTIs were as follows: any 138 (37.7%); M184V 114 (31.1%); T215Y/F 46 (12.6%);D67N 36 (9.8%);M41L 32 (8.7%); K219Q/E 31 (8.5%);K70R 26 (7.1%);and L210W 15 (4.1%). For protease inhibitors (PIs), the most common mutations observed were as follows: any 37 (10.1%);V82A 25 (6.8%); M46I/L 24 (6.6%); L76V 12 (3.3%); I54V 10 (2.7%); L90M 7 (1.9%);and I84V 6 (1.6%).
|
|
|